Viewing Study NCT01033292


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-02-21 @ 2:36 AM
Study NCT ID: NCT01033292
Status: COMPLETED
Last Update Posted: 2016-03-17
First Post: 2009-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ovarian View
None cancer View
None sensitive View
None PARP View
None recurrent View
None platinum-resistant recurrent ovarian cancer View